Richard RussellPresident of Minerva Neurosciences
Richard Russell has more than 20 years of experience leading commercial operations and in developing and implementing sales and marketing activities for major pharmaceutical brands in North America and the European Union.
Mr. Russell joined Ares Allergy Holdings, Inc. (AAH) in October 2014 as Chief Executive Officer, and President and Chief Executive Officer of GREER®. In this role, he leads the U.S. operations of AAH, which includes three operating companies, GREER, Antigen Labs and AllerMed Labs. Through his leadership and business acumen, he is responsible for evolving these companies from market leaders in the U.S. to a unified global leader and innovator in allergy immunotherapy.
Most recently, Mr. Russell held the position of Chief Commercial Officer at Sunovion, where he lead commercial operations in the U.S., Europe and Canada for a portfolio of eight products generating $1.5 billion in revenue. Prior to joining Sunovion, Mr. Russell held the position of U.S. Executive Vice President, Neurodegenerative Diseases and Rheumatology at EMD Serono, where he managed all sales and marketing activities for the multiple sclerosis franchise. Prior to his role at EMD Serono, Mr. Russell was Vice President, Marketing at Sanofi-Aventis leading one of the largest pharmaceutical products in the United States. Earlier in his career, Mr. Russell held several roles in sales and marketing leadership. His pharmaceutical experience spans many therapeutic areas ranging from central nervous system (CNS) disorders, women’s health, cardiovascular disease and neurodegenerative disorders.
Mr. Russell holds a B.A. in Chemistry from Bates College and a M.S. in Organic Chemistry from the University of New Hampshire.